| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |